查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1853619

烟碱酰胺市场依用途、剂型、通路、最终用户和性质划分－2025-2032年全球预测

Niacinamide Market by Application, Form, Distribution Channel, End User, Nature - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，烟碱酰胺市场规模将成长至 10.9026 亿美元，复合年增长率为 4.86%。

关键市场统计数据
基准年2024年 7.456亿美元
预计年份：2025年 7.8266亿美元
预测年份 2032 1,090,260,000 美元
复合年增长率（%） 4.86%

烟碱酰胺的简明策略方向，阐述其在营养、化妆品、饲料和治疗产品生态系统中的多学科相关性。

烟碱酰胺已从一种用途狭窄的成分发展成为一种多功能活性成分，其应用领域涵盖营养、动物保健、化妆品和製药等多个行业。作为维生素B3的重要形式，其功能多样性——从支持皮肤屏障到在饲料和治疗应用中发挥代谢作用——吸引了配方师、製造商和采购团队的广泛关注。本文将从当代市场需求驱动因素和技术考量的角度，对烟碱酰胺进行介绍，并将重点放在决策者需要了解的方面。

如今，产业相关人员面临更复杂的局面，消费者诉求、监管审查、供应链韧性以及原材料来源等因素都会同时影响产品策略。因此，产品经理和研发负责人必须兼顾产品的保质期和配方稳定性与感官和功效预期。同时，采购和供应链专业人员必须应对可能影响原材料来源、合成路线、供应和成本基础的贸易摩擦。

本节透过重点阐述烟碱酰胺的跨领域相关性如何需要製定综合计划，为后续的详细分析奠定了基础。它强调了将科学、监管合规和筹资策略置于商业计划核心的重要性，以维护品牌信誉并满足不断变化的市场需求。

随着消费者、监管和生产重点的变化，烟碱酰胺的来源、配方和产品差异化策略发生了哪些变化？

烟碱酰胺市场正因消费者期望的改变、配方创新和供应链重组而发生巨变。在消费者对洁净标示和多功能活性成分需求不断增长的推动下，各大品牌优先考虑成分透明度和可追溯性，而研发团队则致力于开发能够优化生物有效性和化妆品兼容性的递送系统。这些变化正在重塑市场竞争格局，迫使现有企业和新参与企业重新审视其产品策略和技术资料。

同时，监管趋势和品质期望不断提高，促使製造商采用更高的杂质谱分析和分析证书标准。因此，材料规格和供应商审核已成为筹资策略的关键组成部分。与这种对品质的重视相一致，製造技术的进步，特别是生物合成和结晶/製粒技术的进步，使製造商能够根据颗粒特性、溶解度和感官特性进行差异化生产，从而拓展应用范围。

这种转变也凸显了跨部门协作的重要性。产品开发人员必须与监管事务和采购部门协调，才能将技术优势转化为符合法规的声明和可靠的供应。最终，这将造就一个重视透明度、技术严谨性和快速将新兴科学转化为可扩展配方能力的产业。

2025年美国关税对烟碱酰胺供应链、筹资策略及生产路线选择的影响

美国将于2025年实施关税，这迫使烟碱酰胺价值链上的相关人员重新评估其采购管道和成本结构。贸易政策的变化增加了对多元化供应商组合和紧急时应对计画的需求，尤其是对于那些先前依赖集中式原材料供应的公司。因此，采购团队正在审查合同，并考虑近岸外包和战略库存缓衝，以减轻运输和关税相关中断的影响。

这些关税不仅影响直接成本，也影响供应商的长期选择和合约条款。买家不再只专注于标价，而是越来越重视包含物流、物流波动和库存持有成本在内的总到岸成本分析。这种转变促使一些製造商寻求垂直整合策略，或签订多原产地协议，以便根据关税制度和物流限制获得更大的灵活性。

同时，关税环境正在加速企业对替代生产路线的兴趣。各公司正在评估生物合成路线、植物来源製程以及本地投资的技术和商业性可行性，以降低跨境摩擦带来的风险。从策略角度来看，那些积极重塑供应链并调整商业模式的公司，将更有利于在日益加强贸易保护主义的环境下保护净利率并确保供应的连续性。

全面的細項分析能够准确区分应用、格式、通路、最终用户和材料属性，从而指南技术和商业性优先排序。

有效的細項分析能够揭示价值和风险在应用、剂型、通路、最终用户和材料特性等方面的集中程度。基于应用，市场细分涵盖动物饲料、化妆品、营养保健品、食品饮料和药品。动物饲料进一步细分为水产饲料、牛饲料、家禽饲料和猪饲料。化妆品进一步分为彩妆品、护髮和护肤，其中护肤又细分为抗衰老、提亮和保湿等子类别。营养保健品按胶囊、液体、粉末和片剂区分；食品饮料按烘焙食品、糖果甜点和乳製品区分；药品按非处方药和处方药区分。这种多层次的视角突显了技术规范和监管要求差异最为显着之处。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 由于烟碱酰胺具有提亮肤色和修復皮肤屏障的功效，因此在美容护肤程序中，含有烟碱酰胺的多功能护肤配方的需求正在增加。
  • 清洁美容运动的兴起，强调使用来自永续农业来源的天然成分，并减少化学物质的使用。
  • 随着消费者意识从脸部护肤扩展到其他领域，烟碱酰胺正越来越多地被应用于身体保养和头皮护理。
  • 皮肤科医生推荐的处方笺级烟碱酰胺产品已大量涌现，用于治疗色素沉淀和痤疮。
  • 该公司正在拓展其个人化美容平台，该平台可根据个人皮肤微生物组分析结果提供客製化的烟碱酰胺浓度。
  • 微胶囊化技术的创新可提高化妆品乳液和精华液的稳定性和控制释放
  • 推出联名产品，将烟碱酰胺与胜肽和神经酰胺结合，以发挥协同抗衰老功效
  • 随着亚太地区消费者偏好的转变，韩妆的影响和消费者教育宣传活动推动了烟碱酰胺在亚太地区的使用。
  • 电子商务的成长带动了直接面向消费者的烟碱酰胺品牌数量激增，包括超值装产品和与网红合作的产品。
  • 监管审查和不断变化的品质标准影响药用级烟碱酰胺原料的供应链透明度。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 烟碱酰胺市场依应用领域划分

  • 动物饲料
    • 水产饲料
    • 牛饲料
    • 家禽饲料
    • 猪饲料
  • 化妆品
    • 彩妆
    • 护髮
    • 护肤
      • 抗衰老
      • 提亮
      • 保湿
  • 营养补充品
    • 胶囊
    • 液体
    • 粉末
    • 药片
  • 食品/饮料
    • 麵包店
    • 糖果甜点
    • 乳製品
  • 製药
    • 非处方药
    • 处方药

9. 烟碱酰胺市场按剂型划分

  • 胶囊
  • 液体
  • 粉末
  • 药片

第十章 烟碱酰胺市场（依分销通路划分）

  • 电子商务
    • 公司网站
    • 第三方平台
  • 线下零售
    • 药房和药品商店
    • 专卖店
    • 超级市场和大卖场

第十一章 烟碱酰胺市场（依最终用户划分）

  • 饲料生产商
  • 食品和饮料製造商
  • 个人护理用品製造商
  • 製药商

第十二章 烟碱酰胺市场及其特性

  • 自然的
    • 植物来源
    • 酵母衍生的
  • 合成
    • 生物合成
    • 石油化工衍生性商品

13. 各地区烟碱酰胺市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 烟碱酰胺市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国烟碱酰胺市场概况

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Koninklijke DSM NV
    • Lonza Group AG
    • BASF SE
    • Merck KGaA
    • Roquette Freres
    • Zhejiang Medicine Co., Ltd.
    • Hefei TNJ Chemical Co., Ltd.
    • Wuhan Grand Harvest Biotech Co., Ltd.
    • Shandong Pharmaceutical Group Co., Ltd.
    • Shanghai Lixin Biochemical Technology Co., Ltd.
Product Code: MRR-9E01E2DC4AC3

The Niacinamide Market is projected to grow by USD 1,090.26 million at a CAGR of 4.86% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 745.60 million
Estimated Year [2025] USD 782.66 million
Forecast Year [2032] USD 1,090.26 million
CAGR (%) 4.86%

A concise strategic orientation to niacinamide that frames its multidisciplinary relevance across nutrition, cosmetics, feed, and therapeutic product ecosystems

Niacinamide has evolved from a narrowly focused ingredient to a multifaceted active that intersects nutrition, animal health, cosmetics, and pharmaceuticals. As an essential form of vitamin B3, its functional versatility-ranging from skin barrier support to metabolic roles in feed and therapeutic applications-has expanded interest among formulators, manufacturers, and procurement teams. This introduction frames the ingredient through the lens of contemporary demand drivers and technical considerations that matter to decision-makers.

Industry stakeholders are now navigating a more complex landscape where consumer claims, regulatory scrutiny, supply chain resilience, and raw material provenance exert simultaneous influence on product strategy. Consequently, product managers and R&D leaders must reconcile shelf-life and formulation stability with sensory and efficacy expectations. At the same time, procurement and supply chain professionals must address feedstock origin, synthesis pathways, and potential trade frictions that affect availability and cost basis.

This section sets the stage for the deeper analysis that follows by highlighting how niacinamide's cross-sector relevance necessitates integrated planning. It underscores the importance of placing scientific evidence, regulatory alignment, and sourcing strategy at the center of commercial planning to preserve brand trust and meet evolving market requirements.

How evolving consumer, regulatory, and manufacturing priorities are reshaping niacinamide sourcing, formulation, and product differentiation strategies

The niacinamide landscape is experiencing transformative shifts driven by consumer expectations, formulation innovation, and supply chain reconfiguration. Rising demand for clean-label and multifunctional actives is prompting brands to prioritize ingredient transparency and traceability, while R&D teams invest in delivery systems that optimize bioavailability and cosmetic compatibility. Those changes are reshaping the competitive set and forcing incumbents and new entrants alike to rethink product narratives and technical dossiers.

Simultaneously, regulatory trends and quality expectations have tightened, encouraging manufacturers to adopt higher standards for impurity profiling and certificates of analysis. As a result, material specifications and vendor audits have gained prominence in sourcing strategies. Parallel to these quality-focused changes, advances in manufacturing-particularly bio-synthetic methods and improved crystallization or granulation techniques-are enabling producers to differentiate on particle properties, solubility, and sensory profile, thus broadening application potential.

These shifts also amplify the importance of cross-functional collaboration; product developers must coordinate with regulatory affairs and procurement to translate technical advantages into compliant claims and reliable supply. The net effect is an industry that rewards transparency, technical rigor, and the ability to rapidly translate emerging science into scalable formulations.

Implications of the 2025 United States tariff regime on niacinamide supply chains, procurement strategies, and manufacturing pathway choices

The introduction of tariff measures in the United States in 2025 has compelled stakeholders across the niacinamide value chain to reassess sourcing routes and cost structures. Trade policy changes have heightened the need for diversified supplier portfolios and contingency planning, especially for companies that previously relied on concentrated sources of raw materials. Procurement teams are therefore recalibrating contracts and exploring nearshoring or strategic inventory buffers to mitigate transit and duty-related disruptions.

Beyond immediate cost implications, these tariffs are influencing long-term supplier selection and contractual terms. Buyers are placing greater emphasis on total landed cost analysis, which incorporates duties, logistics variability, and inventory holding costs, rather than focusing solely on headline unit prices. This shift is prompting some manufacturers to pursue vertically integrated strategies or to secure multi-origin contracts that can be flexed according to duty regimes and logistical constraints.

In parallel, the tariff environment is accelerating interest in alternative manufacturing pathways. Firms are evaluating the technical and commercial viability of bio-synthetic routes, vegetable-derived processes, and localized investment to reduce exposure to cross-border friction. From a strategic perspective, companies that proactively redesign supply chains and adjust commercial models will be better positioned to preserve margin and ensure continuity of supply in a more protectionist trade climate.

Comprehensive segmentation analysis revealing precise application, form, channel, end user, and material nature distinctions that guide technical and commercial prioritization

Effective segmentation analysis illuminates where value and risk concentrate across applications, forms, channels, end users, and material nature. Based on Application, the market is studied across Animal Feed, Cosmetics, Dietary Supplements, Food And Beverage, and Pharmaceuticals, with Animal Feed further subdivided into Aquaculture Feed, Cattle Feed, Poultry Feed, and Swine Feed; Cosmetics is elaborated into Color Cosmetics, Hair Care, and Skin Care, and Skin Care is explored through Anti-Aging, Brightening, and Moisturizing subsegments. Dietary Supplements are analyzed by Capsules, Liquid, Powder, and Tablets, while Food And Beverage considers Bakery, Confectionery, and Dairy, and Pharmaceuticals differentiates Over-The-Counter Drugs from Prescription Drugs. This multi-layered view clarifies where technical specification and regulatory expectation vary most dramatically.

Based on Form, the market is studied across Capsules, Liquid, Powder, and Tablets, a segmentation that shapes considerations such as dissolution behavior, storage stability, and compatibility with co-formulants. Based on Distribution Channel, the market is studied across E-Commerce and Offline Retail, with E-Commerce further delineated into Company Website and Third-Party Platforms and Offline Retail elaborated as Pharmacies And Drug Stores, Specialty Stores, and Supermarkets And Hypermarkets; channel choice influences packaging, labeling, and promotional strategies along with regulatory compliance in different territories. Based on End User, the market is studied across Feed Manufacturers, Food And Beverage Manufacturers, Personal Care Manufacturers, and Pharmaceutical Manufacturers, each bringing distinct technical specifications and procurement protocols.

Based on Nature, the market is studied across Natural and Synthetic, with Natural further differentiated into Vegetable-Derived and Yeast-Derived sources and Synthetic subdivided into Bio-Synthetic and Petrochemical-Sourced pathways. Understanding these distinctions enables stakeholders to tailor purity requirements, sustainability messaging, and supply continuity plans. Together, these segmentation layers provide a roadmap for prioritizing product development, regulatory submissions, and commercial positioning based on where technical attributes and buyer expectations align most tightly.

Regional dynamics and regulatory nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence sourcing, compliance, and commercial strategy

Regional dynamics materially shape demand patterns, regulatory contexts, and supply chain pathways for niacinamide. In the Americas, commercial activity is driven by a blend of consumer-facing personal care innovation and a robust supplement and pharmaceutical market that emphasizes clinical substantiation and label transparency. Supply considerations in this region also favor resilience and regulatory alignment, prompting manufacturers to adopt stringent quality controls and to emphasize traceability from feedstock to finished good.

Europe, Middle East & Africa presents a heterogeneous regulatory and commercial landscape where ingredient provenance, sustainability credentials, and safety dossiers carry significant weight. High regulatory thresholds in several European markets require detailed impurity profiles and compliance with advanced cosmetic and pharmaceutical directives, while growing markets in the Middle East and Africa prioritize affordability and scalable supply, creating diverse opportunities for different value propositions.

Asia-Pacific exhibits rapid innovation and production capacity expansion, underpinned by strong manufacturing ecosystems and a fast-moving consumer base that often adopts new formulations quickly. This region combines advanced technical capabilities with growing domestic demand across personal care, dietary supplements, and feed applications. Across these geographies, firms must tailor regulatory strategies, supply chain architectures, and marketing narratives to local expectations while maintaining global consistency in quality and safety.

Competitive dynamics showing how technical differentiation, regulatory capability, and supply reliability define leadership among niacinamide suppliers

The competitive landscape is characterized by a mix of ingredient specialists, chemical producers, and vertically integrated suppliers, each pursuing different strategies to capture value. Leading producers differentiate through technical rigor-offering detailed impurity profiles, customized particle engineering, and application-specific grades-while others emphasize scale and cost competitiveness. Strategic partnerships between ingredient suppliers and brand formulators are becoming more common, allowing for co-development of stabilized systems and proprietary formulations that deliver enhanced performance for targeted applications.

Innovation is also driving consolidated service offerings, where companies combine regulatory support, dossier preparation, and supply continuity assurances to address customer concerns holistically. In addition, several firms are investing in sustainability claims, traceability solutions, and certifications that validate source attribution, particularly for products positioned as natural or vegetable-derived. These investments are not only marketing differentiators but also risk mitigation tools as buyers increasingly demand chain-of-custody information.

Smaller, nimble players are carving niches by targeting specialized application needs-such as ultra-pure grades for pharmaceuticals or sensory-optimized grades for premium cosmetics-while larger firms leverage global footprints to offer multi-origin supply and scale benefits. Collectively, these dynamics create a market where technical capability, regulatory competence, and supply reliability determine competitive positioning.

Actionable strategic priorities for stakeholders to strengthen sourcing resilience, accelerate formulation innovation, and enhance regulatory and sustainability positioning

Industry leaders should adopt a proactive, integrated approach to maintain resilience and capture growth opportunities in the niacinamide market. First, align sourcing strategy with technical and regulatory requirements by integrating total landed cost analysis, supplier audits, and multi-origin contracts into procurement playbooks. This will minimize exposure to trade disruptions while preserving formulation performance expectations. Second, invest in application-specific R&D to create differentiated grades that address stability, solubility, and sensory objectives in cosmetics, formulations for dietary supplements, and targeted feed applications.

Third, strengthen regulatory and quality assurance capabilities by standardizing impurity profiling, expanding dossier completeness, and adopting transparent labeling practices that enhance customer confidence. Fourth, prioritize sustainability and traceability initiatives-such as validated source documentation for vegetable-derived or yeast-derived inputs and credible carbon or stewardship claims-to support premium positioning and meet evolving customer expectations. Fifth, explore strategic partnerships and co-development agreements with brand owners to accelerate route-to-market for novel formulations and to ensure alignment between technical claims and real-world performance.

Finally, implement scenario-based planning that accounts for tariff volatility, logistics interruptions, and raw material availability. By combining technical differentiation with operational agility and rigorous compliance, companies can simultaneously mitigate risk and unlock new opportunities across multiple application segments.

A transparent mixed-methods research approach blending primary practitioner interviews, technical literature review, and triangulated data analysis to ensure robust conclusions

The research underpinning this analysis combines qualitative and quantitative approaches designed to ensure comprehensive coverage of technical, commercial, and regulatory dimensions. Primary inputs included structured interviews with industry practitioners across formulation, procurement, regulatory affairs, and supply chain roles, providing first-hand perspectives on technical specifications, sourcing strategies, and market needs. These interviews were complemented by targeted engagement with manufacturers and end users across personal care, dietary supplements, pharmaceuticals, food and beverage, and feed sectors to capture application-specific insights.

Secondary inputs included peer-reviewed scientific literature, regulatory documentation, and technical white papers that informed discussions on impurity profiling, manufacturing pathways, and formulation best practices. Trade data and customs documentation were examined to identify shifts in flows and to contextualize discussions about duty impacts and logistic constraints. Cross-validation techniques were employed to reconcile differing viewpoints and to triangulate the most robust findings.

Analysis methods prioritized transparency and reproducibility. Technical assertions were corroborated with multiple independent sources, and methodological assumptions were documented to support interpretability by technical and commercial audiences. Wherever applicable, sensitivity assessments were conducted to illustrate how changes in trade policy, feedstock origin, or manufacturing pathways could influence strategic decision-making.

Synthesis of strategic imperatives showing how technical rigor, procurement discipline, and regulatory readiness together determine commercial success in niacinamide

Niacinamide occupies a strategic intersection of nutrition, health, and personal care where technical performance, regulatory compliance, and supply chain resilience converge. Throughout this analysis, recurring themes emerged: the premium placed on material provenance and impurity control, the commercial value of application-specific formulations, and the operational need to manage trade and logistical volatility. These themes point to a market that rewards companies capable of integrating scientific rigor with pragmatic supply strategies.

Looking across applications and geographies, it becomes clear that success will favor organizations that can deliver consistent quality at a competitive total cost while responding nimbly to regulatory variation and evolving consumer expectations. Those that invest in differentiated product grades, transparent sourcing narratives, and targeted partnerships will be better positioned to meet the nuanced demands of cosmetics formulators, supplement manufacturers, feed producers, and pharmaceutical clients.

In summary, the evolutionary trajectory of the niacinamide market underscores the importance of aligning R&D priorities with procurement discipline and regulatory readiness. By doing so, stakeholders can turn technical strengths into commercial advantage and build resilient operations that accommodate both short-term disruptions and long-term shifts in demand.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising demand for multifunctional skincare formulations with niacinamide due to its brightening and barrier repair properties in beauty routines
  • 5.2. Growth of clean beauty movements emphasizing naturally derived niacinamide from sustainable agricultural sources and reduced chemical footprint
  • 5.3. Increasing integration of niacinamide in body care and scalp treatments as broader consumer awareness expands beyond facial skincare
  • 5.4. Surge in dermatologist-backed prescription-strength niacinamide products for targeted treatment of hyperpigmentation and acne
  • 5.5. Expansion of personalized beauty platforms offering customized niacinamide concentrations based on individual skin microbiome analysis
  • 5.6. Innovations in microencapsulation technology enhancing niacinamide stability and controlled release in cosmetic emulsions and serums
  • 5.7. Collaborative product launches featuring niacinamide paired with peptides and ceramides for synergistic anti-ageing benefits
  • 5.8. Regional preference shifts boosting niacinamide usage in Asia-Pacific due to K-beauty influences and consumer education campaigns
  • 5.9. E-commerce growth driving proliferation of direct to consumer niacinamide brands with value pack formats and influencer collaborations
  • 5.10. Regulatory scrutiny and evolving quality standards impacting supply chain transparency for pharmaceutical grade niacinamide ingredients

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Niacinamide Market, by Application

  • 8.1. Animal Feed
    • 8.1.1. Aquaculture Feed
    • 8.1.2. Cattle Feed
    • 8.1.3. Poultry Feed
    • 8.1.4. Swine Feed
  • 8.2. Cosmetics
    • 8.2.1. Color Cosmetics
    • 8.2.2. Hair Care
    • 8.2.3. Skin Care
      • 8.2.3.1. Anti-Aging
      • 8.2.3.2. Brightening
      • 8.2.3.3. Moisturizing
  • 8.3. Dietary Supplements
    • 8.3.1. Capsules
    • 8.3.2. Liquid
    • 8.3.3. Powder
    • 8.3.4. Tablets
  • 8.4. Food And Beverage
    • 8.4.1. Bakery
    • 8.4.2. Confectionery
    • 8.4.3. Dairy
  • 8.5. Pharmaceuticals
    • 8.5.1. Over-The-Counter Drugs
    • 8.5.2. Prescription Drugs

9. Niacinamide Market, by Form

  • 9.1. Capsules
  • 9.2. Liquid
  • 9.3. Powder
  • 9.4. Tablets

10. Niacinamide Market, by Distribution Channel

  • 10.1. E-Commerce
    • 10.1.1. Company Website
    • 10.1.2. Third-Party Platforms
  • 10.2. Offline Retail
    • 10.2.1. Pharmacies And Drug Stores
    • 10.2.2. Specialty Stores
    • 10.2.3. Supermarkets And Hypermarkets

11. Niacinamide Market, by End User

  • 11.1. Feed Manufacturers
  • 11.2. Food And Beverage Manufacturers
  • 11.3. Personal Care Manufacturers
  • 11.4. Pharmaceutical Manufacturers

12. Niacinamide Market, by Nature

  • 12.1. Natural
    • 12.1.1. Vegetable-Derived
    • 12.1.2. Yeast-Derived
  • 12.2. Synthetic
    • 12.2.1. Bio-Synthetic
    • 12.2.2. Petrochemical-Sourced

13. Niacinamide Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Niacinamide Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Niacinamide Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Koninklijke DSM N.V.
    • 16.3.2. Lonza Group AG
    • 16.3.3. BASF SE
    • 16.3.4. Merck KGaA
    • 16.3.5. Roquette Freres
    • 16.3.6. Zhejiang Medicine Co., Ltd.
    • 16.3.7. Hefei TNJ Chemical Co., Ltd.
    • 16.3.8. Wuhan Grand Harvest Biotech Co., Ltd.
    • 16.3.9. Shandong Pharmaceutical Group Co., Ltd.
    • 16.3.10. Shanghai Lixin Biochemical Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS NIACINAMIDE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL NIACINAMIDE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NIACINAMIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NIACINAMIDE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL NIACINAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL NIACINAMIDE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL NIACINAMIDE MARKET SIZE, BY PERSONAL CARE MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL NIACINAMIDE MARKET SIZE, BY PERSONAL CARE MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL NIACINAMIDE MARKET SIZE, BY PERSONAL CARE MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL NIACINAMIDE MARKET SIZE, BY PERSONAL CARE MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL NIACINAMIDE MARKET SIZE, BY PERSONAL CARE MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL NIACINAMIDE MARKET SIZE, BY PERSONAL CARE MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURE, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 307. AMERICAS NIACINAMIDE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 308. AMERICAS NIACINAMIDE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 309. AMERICAS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. AMERICAS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. AMERICAS NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
  • TABLE 312. AMERICAS NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2025-2032 (USD MILLION)
  • TABLE 313. AMERICAS NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
  • TABLE 314. AMERICAS NIACINAMIDE MARKET SIZE, BY COSMETICS, 2025-2032 (USD MILLION)
  • TABLE 315. AMERICAS NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2024 (USD MILLION)
  • TABLE 316. AMERICAS NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2025-2032 (USD MILLION)
  • TABLE 317. AMERICAS NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
  • TABLE 318. AMERICAS NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2032 (USD MILLION)
  • TABLE 319. AMERICAS NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2024 (USD MILLION)
  • TABLE 320. AMERICAS NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2025-2032 (USD MILLION)
  • TABLE 321. AMERICAS NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 322. AMERICAS NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 323. AMERICAS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 324. AMERICAS NIACINAMIDE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 325. AMERICAS NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 326. AMERICAS NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 327. AMERICAS NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
  • TABLE 328. AMERICAS NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2025-2032 (USD MILLION)
  • TABLE 329. AMERICAS NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
  • TABLE 330. AMERICAS NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2025-2032 (USD MILLION)
  • TABLE 331. AMERICAS NIACINAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. AMERICAS NIACINAMIDE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. AMERICAS NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2024 (USD MILLION)
  • TABLE 334. AMERICAS NIACINAMIDE MARKET SIZE, BY NATURE, 2025-2032 (USD MILLION)
  • TABLE 335. AMERICAS NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
  • TABLE 336. AMERICAS NIACINAMIDE MARKET SIZE, BY NATURAL, 2025-2032 (USD MILLION)
  • TABLE 337. AMERICAS NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 338. AMERICAS NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2025-2032 (USD MILLION)
  • TABLE 339. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 340. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 341. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 343. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
  • TABLE 344. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2025-2032 (USD MILLION)
  • TABLE 345. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
  • TABLE 346. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY COSMETICS, 2025-2032 (USD MILLION)
  • TABLE 347. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2024 (USD MILLION)
  • TABLE 348. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2025-2032 (USD MILLION)
  • TABLE 349. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
  • TABLE 350. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2032 (USD MILLION)
  • TABLE 351. NORTH AMERICA NIACINAMIDE MARKET SI